COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 2045: Articles 20441-20450  | Next

Highly potent bispecific sybodies neutralize SARS-CoV-2
Walter, J. D., Hutter, C. A. J., Garaeva, A. A., Scherer, M., Zimmermann, I., Wyss, M., Rheinberger, J., Ruedin, Y., Earp, J. C., Egloff, P., Sorgenfrei, M., Hürlimann, L., Gonda, I., Meier, G., Remm, S., Thavarasah, S., Zimmer, G., Slotboom, D. J., Paulino, C., Plattet, P., Seeger, M. A.
10.1101/2020.11.10.376822 — Posted: 2020-11-10
Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19
Sharma, A.
10.1101/2020.11.10.374777 — Posted: 2020-11-10 Discussion: Onsite | Offsite
Protective efficacy of a SARS-CoV-2 DNA Vaccine in wild-type and immunosuppressed Syrian hamsters
Brocato, R., Kwilas, S. A., Kim, R. K., Zeng, X., Principe, L. M., Smith, J. M., Hooper, J.
10.1101/2020.11.10.376905 — Posted: 2020-11-10
The hydroalcoholic extract of Uncaria tomentosa (Cat's claw) inhibits the replication of novel coronavirus (SARS-CoV-2) in vitro
Yepes-Perez, A. F., Herrera-Calderon, O., Florez-Alvarez, L., Zapata-Cardona, M. I., Yepes, L., Aguilar, W., Rugeles, M. T., Zapata, W.
10.1101/2020.11.09.372201 — Posted: 2020-11-10
CD127 imprints functional heterogeneity to diversify monocyte responses in human inflammatory diseases
Zhang, B., Zhang, Y., Xiong, L., Li, Y., Zhang, Y., Zhao, J., Jiang, H., Li, C., Liu, Y., Liu, X., Liu, H., Ping, Y.-F., Zhang, Q. C., Zhang, Z., Bian, X.-W., Zhao, Y., Hu, X.
10.1101/2020.11.10.376277 — Posted: 2020-11-10
A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples
Liu, T., Chen, Z., Chen, W., Chen, X., Hosseini Asanjan, M., Yang, Z., Li, J., Ho, D., Turay, D., Gheorghe, C., Jones, W., Wang, C.
10.1101/2020.11.10.375022 — Posted: 2020-11-10
Susceptibility of well-differentiated airway epithelial cell cultures from domestic and wildlife animals to SARS-CoV-2
Gultom, M., Licheri, M., Laloli, L., Wider, M., Straessle, M., Steiner, S., Kratzel, A., Thao, T. T. N., Stalder, H., Portmann, J., Holwerda, M., V'kovski, P., Ebert, N., Stokar - Regenscheit, N., Gurtner, C., Zanolari, P., Posthaus, H., Schuller, S., Moreira - Soto, A., Vicente - Santos, A., Corrales - Aguilar, E., Ruggli, N., Tekes, G., von Messling, V., Sawatsky, B., Thiel, V., Dijkman, R.
10.1101/2020.11.10.374587 — Posted: 2020-11-10
In Vitro Efficacy of "Essential Iodine Drops" Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)
Kontos, Z.
10.1101/2020.11.07.370726 — Posted: 2020-11-10
Balancing quarantine and self-distancing measures in adaptive epidemic networks
Horstmeyer, L., Kuehn, C., Thurner, S.
10.1101/2020.11.07.20227595 — Posted: 2020-11-10
A fair efficacy formula for assessing the effectiveness of contact tracing applications
Fowler, A.
10.1101/2020.11.07.20227447 — Posted: 2020-11-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).